rs56064803
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBA1
The NM_021072.4(HCN1):c.201_209delTGGCGGCGG(p.Gly68_Gly70del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0212 in 1,529,748 control chromosomes in the GnomAD database, including 621 homozygotes. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G67G) has been classified as Likely benign.
Frequency
Consequence
NM_021072.4 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 24Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- generalized epilepsy with febrile seizures plusInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- generalized epilepsy with febrile seizures plus, type 10Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HCN1 | NM_021072.4 | c.201_209delTGGCGGCGG | p.Gly68_Gly70del | disruptive_inframe_deletion | Exon 1 of 8 | ENST00000303230.6 | NP_066550.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HCN1 | ENST00000303230.6 | c.201_209delTGGCGGCGG | p.Gly68_Gly70del | disruptive_inframe_deletion | Exon 1 of 8 | 1 | NM_021072.4 | ENSP00000307342.4 | ||
| HCN1 | ENST00000673735.1 | c.201_209delTGGCGGCGG | p.Gly68_Gly70del | disruptive_inframe_deletion | Exon 1 of 9 | ENSP00000501107.1 | ||||
| HCN1 | ENST00000634658.1 | c.201_209delTGGCGGCGG | p.Gly68_Gly70del | disruptive_inframe_deletion | Exon 1 of 2 | 3 | ENSP00000489134.1 | |||
| HCN1 | ENST00000638054.1 | n.-168_-160delTGGCGGCGG | upstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0284 AC: 4277AN: 150482Hom.: 87 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0198 AC: 2842AN: 143504 AF XY: 0.0205 show subpopulations
GnomAD4 exome AF: 0.0204 AC: 28203AN: 1379162Hom.: 534 AF XY: 0.0205 AC XY: 14004AN XY: 681950 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0284 AC: 4280AN: 150586Hom.: 87 Cov.: 32 AF XY: 0.0264 AC XY: 1942AN XY: 73588 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
not specified Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Developmental and epileptic encephalopathy Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at